Both Nrg1−deprived WT and Nf2−/− SCs also upregulated Egfr, which is normally expressed at low levels in SCs but is often increased in schwannomas, some of which respond clinically to pharmacologic EGFR inhibition (Supplementary Fig. 4C)6, 7, 61. This evidence concerns the gene NF2 and schwannoma.